Prevalence of COVID-19 Vaccine Hesitancy and Its Associated Factors among Chronic Disease Patients in a Resource Limited Setting in Ethiopia: A Cross-Sectional Study
Table 2
Attitude towards COVID-19 vaccination among chronic patients in Northwest Ethiopia (N = 422).
Attitude-related questions
Vaccine hesitancy
Yes
No
It is important to get a vaccine to protect the people from COVID-19
Strongly agree
22 (5.2%)
61 (14.5%)
Agree
77 (18.2%)
133 (31.5%)
Neutral
25 (5.9%)
11 (2.6%)
Disagree
57 (13.5%)
7 (1.7%)
Strongly disagree
26 (6.2%)
3 (0.7%)
Pharmaceutical companies are going to develop safe and effective COVID-19 vaccines
Strongly agree
5 (1.2%)
16 (3.8%)
Agree
39 (9.2%)
82 (19.4%)
Neutral
66 (15.6%)
93 (22.0%)
Disagree
60 (14.2%)
19 (4.5%)
Strongly disagree
37 (8.8%)
5 (1.2%)
I believe COVID-19 vaccines made in Europe or America are safer than those made in other world countries
Strongly agree
9 (2.1%)
13 (3.1%)
Agree
17 (4.0%)
57 (13.5%)
Neutral
75 (17.8%)
104 (24.6%)
Disagree
69 (16.4%)
32 (7.6%)
Strongly disagree
37 (8.8%)
9 (2.1%)
My concerns about related side effects will prevent me from taking COVID-19 vaccine
Strongly agree
26 (6.2%)
15 (3.6%)
Agree
70 (16.6%)
78 (18.5%)
Neutral
33 (7.8%)
16 (3.8%)
Disagree
58 (13.7%)
79 (18.7%)
Strongly disagree
20 (4.7%)
27 (6.4%)
Most people will refuse to take the COVID-19 vaccine in Ethiopia
Strongly agree
36 (8.5%)
31 (7.3%)
Agree
89 (21.1%)
102 (24.2%)
Neutral
27 (6.4%)
43 (10.2%)
Disagree
40 (9.5%)
33 (7.8%)
Strongly disagree
15 (3.6%)
6 (1.4%)
The government will make the vaccine available for all citizens for free
